Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04905524 · ClinicalTrials.gov registry record · NA
Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)
A NA study, sponsored by Viome.
- Completed
- Registry status
- NA
- Development phase
- 10,000
- Enrollment target
NCT04905524 is a NA study that has completed, run by Viome. The registered enrollment target is 10,000 participants.
The verdict
NCT04905524, a NA study, has completed, sponsored by Viome.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,000 participants
- Enrollment target
Study Summary
Viome costumers are consented and recruited for this study and complete the questionnaires upon enrollment. Any participant who previously self reported depression, anxiety, or Irritable Bowel Syndrome (IBS) qualify for this study. All participants receive Viome's diet, supplement and recommendations.
Interventions
- DIETARY_SUPPLEMENT VIOME Precision Nutrition Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2022-03-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04905524
The ClinicalTrials.gov registry entry for NCT04905524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VIOME Precision Nutrition Program is the first listed.
NCT04905524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04905524 about?
NCT04905524 is a clinical study titled "Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)". Viome costumers are consented and recruited for this study and complete the questionnaires upon enrollment. Any participant who previously self reported depression, anxiety, or Irritable Bowel Syndrome (IBS) qualify for this study. All participants receive Viome's diet, supplement and recommendatio...
What is the current status of trial NCT04905524?
This trial is currently completed. It is a NA study. The enrollment target is 10,000 participants. The study started on 2020-09-01. Estimated completion is 2022-03-23.
What interventions are being tested in trial NCT04905524?
The interventions under investigation include: VIOME Precision Nutrition Program (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04905524?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.